Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00192257 | Trial to Compare the Safety, Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus in Children With Asthma | PHASE3 | COMPLETED | 2,229 | — | — | Oct 1, 2002 | May 1, 2003 | Oct 3, 2006 | 2 | Belgium |
| Name | Type | Description |
|---|---|---|
| CAIV-T and TIV | BIOLOGICAL | - |
Inclusion Criteria: * who are aged at least 6 years to 17 years of age at the time of enrollment; * with a clinical diagnosis of asthma by one of the following criteria: * An International Classification of Diseases, Ninth revision (ICD-9) code 493 AND ≥one prescription for asthma medication; * OR ...